These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1653794)

  • 1. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats.
    Nagano M; Higaki J; Mikami H; Nakamaru M; Higashimori K; Katahira K; Tabuchi Y; Moriguchi A; Nakamura F; Ogihara T
    J Hypertens; 1991 Jul; 9(7):595-9. PubMed ID: 1653794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
    Makino N; Sugano M; Otsuka S; Hata T
    Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential suppression of pressure-overload cardiac and aortic hypertrophy in rats by angiotensin-converting enzyme inhibitors.
    Wang DQ; Kakizoe E; Kobayashi Y; Shimoura K; Okunishi H
    Jpn J Pharmacol; 1999 Aug; 80(4):333-42. PubMed ID: 10496334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
    Mohabir R; Young SD; Strosberg AM
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
    Mizuno K; Tani M; Hashimoto S; Niimura S; Sanada H; Watanabe H; Ohtsuki M; Fukuchi S
    Life Sci; 1992; 51(5):367-74. PubMed ID: 1385640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic enalapril treatment increases transient outward potassium current in cardiomyocytes isolated from right ventricle of spontaneously hypertensive rats.
    Rodrigues Junior LF; de Azevedo Carvalho AC; Pimentel EB; Mill JG; Nascimento JH
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):225-234. PubMed ID: 27915452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
    Karam H; Heudes D; Bruneval P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
    Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
    Mizuno K; Niimura S; Katoh K; Fukuchi S
    Life Sci; 1994; 54(25):1987-94. PubMed ID: 8201847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.
    Nakano N; Moriguchi A; Morishita R; Kida I; Tomita N; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1997 Dec; 30(6):1448-54. PubMed ID: 9403566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy.
    Nagano M; Higaki J; Nakamura F; Higashimori K; Nagano N; Mikami H; Ogihara T
    Hypertension; 1992 Jun; 19(6 Pt 2):708-12. PubMed ID: 1534315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trandolapril dose-response in spontaneously hypertensive rats: effects on ACE activity, blood pressure, and cardiac hypertrophy.
    Jouquey S; Stepniewski JP; Hamon G
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S16-8. PubMed ID: 7527096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
    Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
    Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats.
    Higashimori K; Nakamaru M; Tabuchi Y; Nagano M; Mikami H; Ogihara T; Inagami T
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):56S-59S. PubMed ID: 2009150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in left ventricular mass in normotensive and spontaneously hypertensive rats given enalapril.
    Mooser V; Casley D; Trinder D; Paxton DL; Johnston CI
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):341-4. PubMed ID: 1829664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrarenal angiotensin converting enzyme inhibition in spontaneously hypertensive rats.
    Aihara H; Ogawa H; Kasuya A; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
    Eur J Pharmacol; 1999 May; 373(1):35-40. PubMed ID: 10408249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular actions and tissue-converting enzyme inhibitory effects of chronic enalapril and trandolapril treatment of spontaneously hypertensive rats.
    Chevillard C; Brown NL; Jouquey S; Mathieu MN; Laliberté F; Hamon G
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):297-301. PubMed ID: 2476605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of left ventricular hypertrophy by converting enzyme inhibition in 12-15-month-old spontaneously hypertensive rats: effects on coronary resistance and ventricular compliance in normoxia and anoxia.
    Amrani FC; Cheaw SL; Chevalier B; Paolaggi F; Jouquey S; Hamon G; Swynghedauw B
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):155-65. PubMed ID: 7511729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
    Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
    Ruzicka M; Yuan B; Harmsen E; Leenen FH
    Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.